EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of Microcapillary Blood Sampling Devices for Use in Anti‐Doping

Laura Lewis, Monika Smith, Kristin Boutard, Matthew Fedoruk iD, Geoff Miller iD

Drug Testing and Analysis · 2025-08 · 17 (8) · 1145-1149

DOI: 10.1002/dta.3818 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Drug Testing and Analysis, online erschienen am 19.10.2024. Verfasst von Laura Lewis und 4 weiteren Autor:innen. Beteiligte Einrichtung: United States Anti-Doping Agency, Colorado Springs, Colorado, USA. Hauptthemen laut MEDLINE: Doping in Sports, Substance Abuse Detection, Blood Specimen Collection. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blood collection is an important facet of anti‐doping testing, forming the basis of the hematological module of the athlete biological passport (ABP). Presently, whole blood is collected via venepucture under standardized conditions, in accordance with the World Anti‐doping Agency's International Standard for Testing and Investigations (ISTI). Advances in capillary whole blood collection technology now afford the ability to collect microvolumetric capillary whole blood from the upper arm (or other suitable vascular location such as the abdomen) that is “needle‐free” and virtually painless. Previous work has demonstrated the suitability and feasibility of capillary whole blood compared with venous using the Tasso+ device. Recently, other microcapillary devices have received FDA approval increasing the options available to the anti‐doping community. The present study extends previous work, by collecting microliter capillary whole blood samples via two different FDA approved devices (RedDrop and the Tasso+ device) to compare with venous blood collected simultaneously. Ten participants provided three matched blood samples (2× capillary and 1× venous) in accordance with WADA ABP guidelines for blood sample collection, for a total of 30 samples. Capillary samples from both devices showed excellent laboratory agreement with venous blood for all CBC parameters, with the exception of platelets. Excellent laboratory agreement was also observed between the two microcapillary collection devices. Irrespective of the device, microcapillary blood collection provides a valid alternative to venous blood collection for ABP purposes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Doping in SportsSubstance Abuse DetectionBlood Specimen CollectionHumansCapillariesMaleAdultFemale

Stichwörter der Autor:innen

anti‐dopingbiological passportblood collectioncapillary blood

Autor:innen und Institutionen

  • United States Anti-Doping Agency, Colorado Springs, Colorado, USA.
  • Sports Medicine Research Testing Laboratory, Salt Lake City, Utah, USA.

ORCID-Profile: Matthew Fedoruk, Geoff Miller

Zitieren

APA

Lewis, L., Smith, M., Boutard, K., Fedoruk, M., & Miller, G. (2025). Comparison of Microcapillary Blood Sampling Devices for Use in Anti‐Doping. Drug Testing and Analysis, 17(8), 1145-1149. https://doi.org/10.1002/dta.3818

Vancouver

Lewis L, Smith M, Boutard K, Fedoruk M, Miller G. Comparison of Microcapillary Blood Sampling Devices for Use in Anti‐Doping. Drug Testing and Analysis. 2025;17(8):1145-1149. doi:10.1002/dta.3818

BibTeX
@article{Lewis2025,
  author = {Lewis, Laura and Smith, Monika and Boutard, Kristin and Fedoruk, Matthew and Miller, Geoff},
  title = {Comparison of Microcapillary Blood Sampling Devices for Use in Anti‐Doping},
  journal = {Drug Testing and Analysis},
  year = {2025},
  volume = {17},
  number = {8},
  pages = {1145--1149},
  doi = {10.1002/dta.3818}
}
Kostenlos starten →